- In March 2023, the U.S. Food and Drug Administration (FDA) granted premarket approval for the NeuRx DPS. This system utilizes electrical stimulation to activate the diaphragm muscles, enabling patients with high spinal cord injuries to breathe without mechanical ventilators.
